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Objectives: Steroids,usedinpretermprematureruptureofmembranes(pPROM),toreducetheriskofmorbidity
and mortality of the preterm neonate, impair the maternal polymorphonuclear leukocyte (PMN)-based immune
system.In spite of combination with antibiotics, prenatal and postnatal bacterial infections of mother and child are
frequent.This pilot studyfocuses on the influence of steroidsin pPROM on maternal PMN functional capacity and
subsequent infections.
Methods: After opting for expectant management, eight women with pPROM and no signs of infection were
treated by steroids (betamethasone 5.7 mg, i.m. every 24 hours,for three days) and antibiotic therapy with either
amoxicillin and clavulanic acid, piperacillin or ampicillin i.v. up to delivery. The conventional inflammation para-
meters of PMN blood count and C-reactive protein (CRP) were measured daily in parallel with PMN migratory
capacity towards N-formyl-methionyl-leucyI-phenylalanine stimulation and underblankconditions,estimated bya
whole blood membrane filter assay.
Results: In all patients PMN migration decreased during the application of steroids. Three patients showed
a decrease in PMN migration below critical values and in spite of antibiotic prophylaxis acute pyelonephritis
developed 2–6 days later. PMN count and CRP were not predictive of maternal infection.
Conclusion: ReducedPMN function,causedby steroid treatment in pPROM,is suggestedto be a reasonfor seri-
ousbacterialinfectionsinspiteofantibioticprophylaxis.PMNmigrationreflectsindividualPMNdefensivecapacity.
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In preterm premature rupture of membranes
(pPROM), bacterial and fungal infections are a
major cause of maternal and fetal morbidity and
mortality1–4. After rupture of the amniotic mem-
brane,theopenedamnioticsacfacilitates theaccess
of pathogens to the amniotic fluid and membrane.
To reduce the risk of complications such as
respiratory distress syndrome, intraventricular
hemorrhage and mortality of the preterm neonate
antenatal administration of corticoid drugs is
widely used3,5,6. To prevent maternal and fetal
infections, antibiotics are used in patients with
pPROM3,5–8. Nonetheless, infections are frequent
in mother and child3,5–8.
Polymorphonuclear leukocytes (PMN) repre-
sent the first line of defense against bacterial and
fungal pathogens9,10. For an effective host defense,
thePMN-based immune system must beintact.In
a series of clinical studies with various diseases, our
workinggroupdemonstrated thatPMNmigration
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Clinical study 227is a reliable marker for the effectiveness of the
PMN-based immune system. With increasing
duration and degree of impaired PMN migration,
therisk ofinfectionincreased inparallel, eventually
resulting in the clinical manifestation of an infec-
tion.In thisway,it waspossible topredictimpend-
ing infections11–15.
The aim of the present pilot study was to
examine whether these experiences can be trans-
ferred to pPROM. In pPROM patients treated
with steroids and antibiotics, PMN migration was
measured daily until discharge from the hospital.
To demonstrate the predictive relevance, the
course of PMN migration was retrospectively
correlated with the occurrence of infections. As a
comparison, the conventional inflammation
parameters PMN blood count and C-reactive
protein (CRP) were measured in parallel.
SUBJECTS AND METHODS
Test subjects
Eight women with no signs of infection and
pPROM were opted for expectant management.
Differential blood count and assessment of clinical
symptoms were done daily, starting with hospital-
ization immediately after pPROMuntildischarge.
PROM was confirmed by speculum examination,
AMNI-Check® (AMNI-Check, Lateral-Flow-
Immunoassay, Mast-Diagnostica Laboratoriums-
Präparate Gmbh, D-23858 Reinfeld) and sono-
graphy. Rupture of membranes continued until
delivery.
Immediately after hospitalization for pPROM,
10 ml blood was taken from the cubital vein for
determination within 20 min of PMN migration,
leukocyte and differential blood counts and CRP.
After opting for expectant management, we
treated all eight women with 5.7 mg betametha-
sone i.m. every 24 h for 3 days (CELESTANÒ
biphase – ampoules, SP Labo, Heist, Belgien),
combined with antibiotic prophylaxis, either
amoxicillin and clavulanic acid i.v, piperacillin i.v.
or ampicillin i.v. up to delivery. Blood samples
were taken daily at 8 a.m.
Fetal heart rate was evaluated daily. Four
preterminfantsweredelivered byCesarean section
because of non-reassuring fetal heart rate pattern,
as indicated by declining fetal heart rate upon
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GA – pPROM, gestational age at pPROM; GA – Del, gestational age at delivery; Del – mod, delivery modus; c.s, Cesarean section;
sp, spontaneous; Steroids, i.m. before delivery; Antibiotics, i.v. before delivery; A1, amoxicillin and clavulanic acid (2.2 g i.v. single shot);
A2, amoxicillin and clavulanic acid (3 ´ 2.2 g i.v. 4 days); A3, amoxicillin and clavulanic acid (3 ´ 2.2 g i.v. 7 days); P1, piperacillin (2 ´ 4 g i.v.
13 days); P2, piperacillin (3 ´ 4 g i.v. 5 days); S1, ampicillin (3 ´ 2 g i.v. 3 days); TMI – FMLP, values of total migration indices under FMLP
stimulation below the critical mark of ‘6’; TMI – Q, values of the total migration indices FMLP/blank quotients below the critical mark of
‘0.3’; Infection – Mother, Onset/Infection, Onset of maternal infection in days, after decreased TMI-FMLP and TMI-Q values; + yes; - no
Table 1 Patient data and correlation to infectioncardiotocography. Four preterm infants were
delivered spontaneously and there was one still-
birth, due to prolapsed umbilical cord in the 27th
week of pregnancy (Patient 5, Table 1). None of
the eight women had any signs of infection or
chorioamnionitis upon delivery. All patients gave
written and verbal informed consent and the study
wasapprovedbythehospital’sEthicsCommittee.
PMN blood count
Blood leukocyte count and differentiation/ml was
done in a Coulter-Counter ZM.
PMN migration
PMN migration was measured with a novel
membrane filter migration assay. The main feature
of this device is the use of fresh whole blood. In
brief, 300 ml fresh whole blood anticoagulated
with ammonium heparin (NH4 heparin syringes,
Sarstedt, Nümbrecht, Germany) was diluted with
HBSS 1:4 and processed 20 min after withdrawal
without cell separation to avoid cell stimulation14.
The migration device includes a cellulose nitrate
membrane migration filter (3 mm pore size,
140 mm thick, Sartorius, Göttingen, Germany)
and a chemoattractant depot containing the
bacterial chemotactic peptide N-formyl-
methionyl-leucyl-phenylalanine (FMLP) in solid
form, and in parallel, blank chambers, each in
triplicate. FMLP dissolves in the blood suspension
pipettedintothechamberandformsa chemotactic
gradient within the migration filter. The number
of PMNs to penetrate into the migration filter is
counted in consecutive layers of 10 mm through-
out the entire depth of the filter. A count contains
the number of immigrated PMNs and their distri-
bution within the filter. In this study two relative
PMN functions were considered: ‘total migration
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Figure 1 Total migration index-FMLP (TMI-FMLP).
Individual data of the five patients without infection
(NO), and the three patients with infection: Bl (before
infection), Al (after onset of infection). The discrimina-
tive value of 6 is considered to be a risk factor and pre-
dictive for infection
Figure 2 Quotient TMI-FMLP/TMI-Blank (Q-TMI).
Individual data of the five patients without infection
(NO), and the three patients with infection: Bl (before
infection), Al (after onset of infection). The discrimina-
tive value of 0.3 is considered to be a risk factor and pre-
dictive for infectionindex’ (TMI), i.e. the percentage of PMNs
migrating into the filters upon FMLP stimulation
and under blank conditions; the FMLP/Blank-
quotient(Q), i.e. PMN reactivity to FMLP stimu-
lation in comparison with the blanks. For more
details about the method see article by Egger and
colleagues11.
CRP
CRP was measured by Tina-quant® CRP
(BM/Hitachi 704/705/71/911 SYS1, 1299859).
Diagnosis of infections
Apparent maternal infection (pyelonephritis) was
established via urine sediment, urine culture and
clinical signs (nephralgia, temperature > 38°C).
Neonatal infection was confirmed by PMN
band forms, increased CRP and clinical signs
of centralization of circulation, hypotension,
tachypnea, elevated temperature). All neonatals
underwent chest X-ray to identify neonatal pneu-
monia. The causative microorganism in the new-
born of patient 1 was found by wound smear and
culture. In the newborn of patient 3 no causative
microorganism could be found.
Statistical analysis
The individual parameters TMI-FMLP, TMI-
blank, the quotient Q, PMN blood counts and
CRP were divided in three groups according to
the clinical course of the patients: women without
infection (NO) and women who developed infec-
tions; their values were separated into the groups
before clinical manifestation of infection (BI) and
after onset of infection (AI), and presented as
scatter plots (Figures 1–3). The limits distinguish-
ing an uneventful course from future infectious
complications were established empirically by
visual estimation and were chosen to achieve a
minimal error rate.
RESULTS
Maternal infections
After decrease under the critical marks of
TMI-Q < 0.3 and TMI-FMLP < 6 patients 1, 2
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Figure 3 Time profile of total migration indices (TMI), PMN blood counts/ml (PMN) and the duration of steroid
therapy (CEL) and antibiotic prophylaxis (AB) of patient 2 (pyelonephritis). Abscissa: Days after pPROM are equal to
days with monitoring. Left ordinate: TMI-FMLP (full stroke), the lower limit is 6. TMI-Blank (fine line). PMN blood
counts (PMN, fine dotted fine). Right ordinate: The FMLP/Blank Quotient (Q, thick dotted line), the lower limit is 0.3.
Note that during application of steroids (CEL) PMN functional ability (TMI-Q and TMI-FMLP) decreased very impres-
sively. Infection (pyelonephritis) occurred three days later (day 5)and 3 developed acute pyelonephritis 2–5 days
later (Figures 1–3, Table 1). The microorganisms
foundin culturewere:forPatient1, Escharichia coli;
Patient 2, E. coli, Citrobacter diversus; Patient 3,
E. coli, Klebsiella pneumoniae, Group D Streptococcus.
Patient 4 showed an isolated decrease of
TMI-FMLP < 6, without subsequent infection.
The PMN reactivity of patients 5, 6, 7, and 8,
who did not develop infections, did not
dropunderthecritical marks of TMI-Q < 0.3 and
TMI-FMLP < 6.
Neonatal infections
The newborn of patient 1 developed gangrene of
theleft lowerleg;thecausative microorganism was
Citrobacter species. The newborn of patient 3
developed early onset sepsis. The six other new-
bornsdid notshow anysigns of neonatal infection.
All neonatals underwent chest X-ray, none of
them showed any sign towards neonatal
pneumonia.
PMN blood counts and CRP
The PMN blood counts/ml of patients 1, 2, 3
suffering from infections were within the range of
those without infection (NO) (Figure 4).
During expectant management, serum CRP
levels of all mothers were similar, between 0.1 up
to 10 mg/l. Serum CRP levels of all mothers
rapidly rose immediately after vaginal delivery or
Caesarean section up to 20 mg/l16–18 and, thus,
masked the reaction to infection.
DISCUSSION
Preterm PROM increases maternal and fetal risk
of infection and preterm labor complications1–4.
Prenatal use of steroids and antibiotic prophylaxis
are able to prolong the time between pPROM
and delivery and to improve the initial condition
of the newborn1–8. However, this therapy is
applied without reliable knowledge of its effects
on PMN function. PMNs play a crucial role in
the host defense against bacterial and fungal
pathogens9,10 and the maternal PMN functional
state can be hampered by steroid treatment.
This first approach to the problem ‘definition
of the infection risk in pPROM’ suggests that
an impairment of PMN migratory efficacy is a
predictive marker for infection, and that in an
organism with an impaired immune defence,
infections can develop despite antibiotic prophy-
laxis. Our data are in good agreement with earlier
studies by our working group on other topics
demonstrating thatthemerenumberofcirculating
PMNs does not necessarily reflect their immuno-
logical efficiency, and functional parameters are
much more reliable. Before infections, we often
found a low PMN readiness to migrate that
coincided with elevated blood counts feigning an
effective host defense11–15.
We conclude that the conventional marker for
PMNefficiencyisnotreliable. However,thevalue
of PMN migration in pPROM and perinatal
infections has to be consolidated in more compre-
hensive studies.
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Figure 4 PMN blood counts /ml. Individual PMN
blood counts/ml of the five patients without infection
(NO), and the three patients with infection: Bl (before
infection), Al (after onset of infection). The PMN blood
counts/ml of patients before (Bl) and after onset of infec-
tion (Al) are within the values of those patients without
(NO) infectionsREFERENCES
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